Research and Markets has announced the addition of the Halal Testing Markets - Regulatory Trends in Southeast Asia by AcuBiz Consulting to their portfolio.
According to the report, demand for halal testing is on the rise worldwide. Halal
certification can open up significant global trade opportunities for
companies in the food, cosmetics, and pharmaceutical industry segments.
This is being viewed as a means to encourage exports, tourism and
research. Middle East and North Africa (MENA) are the most promising regions for halal products even though demand is global and growing. Economic opportunities for halal food exist even in non-Muslim countries, since halal certification is being perceived as an assurance of quality by consumers in general.
Halal standards are applicable not
only to the end products but also to the ingredients and processes used in the manufacturing, packaging, labelling, and transportation. The
halal economy covers stakeholders such as the butchers
involved in ritual slaughtering of meat and poultry, food manufacturers,
retailers, restaurant chains, shipping companies, and halal
certification agencies.
Southeast Asia is at the forefront of developing
halal testing regulations and has established processes for halal
certification related to several industry sectors. Malaysia is leading
the efforts in the region.
Since 2006, Malaysia has been recognised as an
international halal-hub for the production and trade of halal products
and services.
This report focuses on the regulatory trends
related to halal testing and halal certification. Particular emphasis is
on the new opportunities being created by this emerging trend for
technology companies with diagnostic platforms that can offer accurate
and fast detection of non-halal components in various sample matrices in
the areas of food, pharmaceuticals and cosmetics.
Companies mentioned in the report include Agilent Technologies, Asia-Pacific Special Nutrients, BIORON, Capital Biotech, Eurofins, Genon Laboratories, Halalysis, InstantLabs, Lynxcells Biosciences (formerly BST Consultancy & Services), Olipro Biotechnology, Profound Kestrel Laboratories (a subsidiary of Revongen Corporation Centre), Progenus, QIAGEN, Revongen Corporation Centre, and XEMA, formerly known as Xema-Medica.